食品伙伴網(wǎng)訊    據(jù)美國食品藥品管理局（FDA）消息，11月19日美國FDA發(fā)布通告，批準(zhǔn)轉(zhuǎn)基因鮭魚用于食品并發(fā)布相應(yīng)標(biāo)示指南。

    與普通鮭魚相比，AquAdvantage轉(zhuǎn)基因鮭魚生長速度更快，在營養(yǎng)方面FDA未發(fā)現(xiàn)二者的差別。

    美國FDA稱，已經(jīng)對轉(zhuǎn)基因鮭魚的數(shù)據(jù)進(jìn)行詳細(xì)分析與評估，發(fā)現(xiàn)符合批準(zhǔn)條件，食用這種鮭魚是安全的。

    美國FDA還發(fā)布兩項指南，轉(zhuǎn)基因鮭魚自愿性標(biāo)示指南草案以及轉(zhuǎn)基因植物自愿性標(biāo)示最終指南。

    部分原文報道如下：

    based on sound science and a comprehensive review, the U.S. Food and Drug Administration is taking several important steps today regarding food from genetically engineered （GE） plants and animals, including the first approval for a genetically engineered animal intended for food, AquAdvantage Salmon. The agency is also issuing two guidances for manufacturers who wish to voluntarily label their products as containing ingredients from GE or non-GE sources: a draft guidance on labeling foods derived from Atlantic salmon, and a final guidance on foods derived from GE plants.

    原文鏈接：<http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473249.htm>